Download (992Kb) - Repozitorij Medicinskog fakulteta Sveučilišta u ...

128. Gum R, Wang H, Lengyel E, Juarez J, Boyd D. Stimulation of 92-kDa gelatinase Bpromoter activity by ras is mitogen-activated protein kinase kinase 1-independent andrequires multiple transcription factor binding sites including closely spaced PEA3/etsand AP-1 sequences. Oncogene. 1997; 14:1481-1493.129. Chang DI, Hosomi N, Lucero J, Heo JH, Abumiya T, Mazar AP, del Zoppo GJ. Activationsystems for latent matrix metalloproteinase-2 are upregulated immediately afterfocal cerebral ischemia. J Cereb Blood Flow Metab. 2003; 23:1408–1419.130. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002; 39:279–291.131. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediateddisruption of tight junction proteins in cerebral vessels is reversed bysynthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb BloodFlow Metab. 2007; 27:697–709.132. Montaner J, Alvarez-Sabín J, Molina C, Anglés A, Abilleira S, Arenillas J, MonasterioMAGJ. Matrix metalloproteinase expression after human cardioembolic stroke: temporalprofile and relation to neurological impairment. Stroke. 2001: 32:1759–1766.133. Montaner J, Alvarez-Sabín J, Molina C, Anglés A, Abilleira S, Arenillas J, MonasterioMAGJ. Matrix metalloproteinase expression is related to hemorrhagic transformationafter cardioembolic stroke. Stroke. 2001; 32:2762–2767.134. Rosenberg GA, Yang Y. 2007. Vasogenic edema due to tight junction disruption bymatrix metalloproteinases in cerebral ischemia. Neurosurg Focus .2007; 22:E4.135. Janigro D, West GA, Nguyen TS, Winn HR. Regulation of blood-brain barrier endothelialcells by nitric oxide. Circ Res. 1994; 75:528–538.136. Yamamoto T, Bing RJ. Nitric oxide donors. PSEBM. 2000; 225:200-206.137. Murad F. Drugs used for the treatment of angina: organic nitrates, calcium channelblockers, and beta-adrenergic antagonist. U: Goodman Gilman A, Rall TW, Nies AS,Taylor P, urednici. Goodman and Gilman’s the pharmacologicals basis of therapeutics.New York: Pergamon Press; 1990. str. 764-783.138. Tassorelli C, Joseph SA, Buzzi MG, Nappi G. The effect of the central nervous system ofnitroglycerin – putative mechanisms and mediators. Progr Neurobiol. 1999; 57:607-624.139. Tassorelli C, Joseph CA. Systemic nitroglycerin induces Fos immunoreactivity i brainstem and forebrain structures of the rat. Brain Res .1995; 682:167-178.140. Reuter U, Bolay H, Jansen-Olesen I, Chiarugi A, Sanchez del Rio M, Letourneau R etal. Delayed inflammation in rat meninges: implications for migraine pathophysiology.Brain. 2001; 124:2490-2502.69